Bowel Perforation in Covid-19 Case Series


COD: 20_2021_3614-1 Categorie: ,

Donato Sciano, Raffaele D’Ambrosio, Antonello Maresca, Silvio Buonincontro, Francesco Mariano, A. Lenta, Albertlesandra D’Agostino
Ann. Ital. Chir., 2021 92, 5: 589-591

La mia nuova descrizione qui!

Price of a print issue €25.00

OBJECTIVE: To describe the clinical characteristics and outcomes of patients with coronavirus disease 2019(COVID-19)
who developed bowel perforation.
MATERIALS AND METHODS: This case series was conducted in Emergency Department of AORN Sant’Anna and S.
Sebastiano located in Caserta. All patients resulted positive to SARS-Cov-2 in nasopharyngeal swabs whith a positive
laboratory test for SARS-CoV-2 from real time reverse transcription polymerase chain reaction(RT-PCR) as well as bowel
perforation which was identified by abdominal CT, from September 2020 to December 2020.
RESULTS: A total of five patients were identified with Bowel perforation occurred despite all patients being on anticoagulation.
All patients were Italian, predominantly male(four patients) with an average age of 60 years and the most
common comorbidity was hypertension, diabetes and obesity.
DISCUSSION: Bowel perforation in COVID-19 is clinically significant with high morbidity and mortality. In our series
40% of patients who were diagnosed of bowel perforation died. Average time to death after bowel perforation diagnosis
was 6 days.
CONCLUSION: We describe a case series of COVID-19 patients who developed bowel perforation.